Abstract
We performed a meta-analysis of 14 genome-wide association studies of coronary artery disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of European descent followed by genotyping of top association signals in 56,682 additional individuals. This analysis identified 13 loci newly associated with CAD at P < 5 × 10−8 and confirmed the association of 10 of 12 previously reported CAD loci. The 13 new loci showed risk allele frequencies ranging from 0.13 to 0.91 and were associated with a 6% to 17% increase in the risk of CAD per allele. Notably, only three of the new loci showed significant association with traditional CAD risk factors and the majority lie in gene regions not previously implicated in the pathogenesis of CAD. Finally, five of the new CAD risk loci appear to have pleiotropic effects, showing strong association with various other human diseases or traits.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330, 1041–1046 (1994).
Schunkert, H., Erdmann, J. & Samani, N.J. Genetics of myocardial infarction: a progress report. Eur. Heart J. 31, 918–925 (2010).
Preuss, M. et al. Design of the Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22,000 cases and 60,000 controls. Circ. Cardiovasc. Genet. 3, 475–483 (2010).
Clarke, R. et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361, 2518–2528 (2009).
Trégouët, D.A. et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat. Genet. 41, 283–285 (2009).
Psaty, B.M. et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. 2, 73–80 (2009).
Nitz, I. et al. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol. Nutr. Food Res. 51, 1046–1052 (2007).
Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423–428 (2008).
Zhong, H. et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 6, e1000932 (2010).
Ge, B. et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat. Genet. 41, 1216–1222 (2009).
Hindorff, L.A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362–9367 (2009).
Brown, M.S. & Goldstein, J.L. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 185, 61–63 (1974).
Linsel-Nitschke, P. et al. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease—a Mendelian Randomisation study. PLoS ONE 3, e2986 (2008).
Musunuru, K. et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714–719 (2010).
Linsel-Nitschke, P., Samani, N.J. & Schunkert, H. Sorting out cholesterol and coronary artery disease. N. Engl. J. Med. 363, 2462–2463 (2010).
Manolio, T.A. et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).
Wilson, P.W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847 (1998).
Ripatti, S. et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376, 1393–1400 (2010).
Assimes, T.L. et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum. Mol. Genet. 17, 2320–2328 (2008).
Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491–1493 (2007).
Samani, N.J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443–453 (2007).
Erdmann, J. et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur. Heart J. 32, 158–168 (2011).
Erdmann, J. et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 41, 280–282 (2009).
Winkelmann, B.R. et al. Rationale and design of the LURIC study—a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2, S1–S73 (2001).
Lehrke, M. et al. CXCL16 is a marker of inflammation, atherosclerosis and acute coronary syndromes in humans. J. Am. Coll. Cardiol. 49, 442–449 (2007).
Kathiresan, S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334–341 (2009).
McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007).
WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Anonymous. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 129, 687–702 (1989).
Wichmann, H.E., Gieger, C. & Illig, T. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1, S26–S30 (2005).
Pastinen, T. & Hudson, T.J. Cis-acting regulatory variation in the human genome. Science 306, 647–650 (2004).
Li, Y., Willer, C.J., Ding, J., Scheet, P. & Abecasis, G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3, e114 (2007).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
Bagos, P.G. A unification of multivariate methods for meta-analysis of genetic association studies. Stat. Appl. Genet. Mol. Biol. 7, Article31 (2008).
Bagos, P.G. & Nikolopoulos, G.K. A method for meta-analysis of case-control genetic association studies using logistic regression. Stat. Appl. Genet. Mol. Biol. 6, Article17 (2007).
Gudbjartsson, D.F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342–347 (2009).
Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009).
Acknowledgements
We thank the participants and staff in each of the studies who contributed to the present article. The sources of funding are listed in the supplementary materials.
Author information
Authors and Affiliations
Consortia
Contributions
Manuscript writing: H.S., I.R.K., S.K., M.P.R., T.L.A., H.H., A.F.R.S., P. Deloukas, R.R., R.M., J.E., N.J.S.
GWAS meta-analysis samples, genotyping and analysis: H.S., I.R.K., S.K., M.P.R., T.L.A., H.H., M.P., A.F.R.S., M.B., C.G., D. Absher, D. Ardissino, K.A., S.G.B., A.J.B., J.C.B., E.B., P.S.B., M.S.B., L.C., A. Deghan, S.D., P. Diemert, J.D., A. Doering, N.E.E.M., R.E., S.E., M.F., A.R.F., S.G., J.R.G., E.H., A.H., T.I., C.I., M.A.K., J.W.K., A.K., R.L., M.L., W.L., C.L., C.M., T. Meitinger, O.M., V.M., K.M., T. Morgan, J.N., C.P.N., A.P., L.Q., D.J.R., V.S., A. Schäfer, A. Schillert, S.S., J.S., S.M.S., D.S.S., K.S., G. Thorgeirsson, G. Thorleifsson, M.T., A.G.U., B.F.V., G.A.W., H.E.W., C.W., P.S.W., J.C.M.W., B.J.W., T.Z., A.Z., F.C., L.A.C., T.Q., W.M., C.H., S.B., A.S.H., P.D., U.T., R.R., J.R.T., C.J.O., R.M., J.E., N.J.S.
Replication phase samples, genotyping and analysis: H.S., I.R.K., S.K., M.P.R., H.H., M.P., H.A., S.A., K.A., T.L.A., J.L.A., D. Ardissino, D. Absher, T.A.B., L.C.B, D.M.B., K.B., S.M.B., M.J.B., I.B., J.F.C., R.W.D., G.D., R.D., S.G.E., J.C.E., U.d.F., B.G., D.G., V.G., N.H., S.L.H., B.D.H., C.I., G.T.J., J.W.J., L.M.K., J.W.K., J.J.P.K., K.-T.K., G.K., D.L., K.L., P.L.-N., A.J.L., P.M.M., N.M., P.P.M., P.A.M., T. Morgan, T. Meitinger, T.W.M., J.B.M., S.C., M.M.N., O.O., F.P., R.S.P., C.C.P., A.A.Q., L.S.R., F.R.R., D.R., M.L.S., M.S.S., S. Sivapalaratnam, T.B.S., J.D.S., N.S., J.A.S., T.Q., K. Stark, K. Stirrups, M. Stoll, W.H.W.T., A.M.v.R., N.J.W., S.Y., P.D., U.T., R.R., R.M., J.E., N.J.S.
Analysis group: I.R.K., M.P., D. Absher, L.C., E.H., M.L., K.M., A. Schillert, G. Thorleifsson, B.F.V., G.A.W., L.A.C., J.R.T.
Biological analyses: H.S., T.L.A., H.H., M.B., C.G., Z.A., P.S.B., V.C., J.F., S.G., P.L.-N., G.L., S.M., C.R., E.S., M.T., F.C., A.H.G., T.Q., C.H., W.H.O., P.D., U.T., J.E., N.J.S.
CARDIoGRAM consortium executive group: H.S., S.K., M.P.R., J.E., N.J.S.
CARDIoGRAM consortium steering group: H.S., I.R.K., S.K., M.P.R., T.L.A., E.B., R.L., A.Z., C.H., A.S.H., U.T., J.R.T., R.M., J.E., N.J.S.
Corresponding authors
Ethics declarations
Competing interests
Genotyping of PennCATH and Medstar was supported by GlaxoSmithKline. D.M.W., M.C.W. and V.M. are employees of GlaxoSmithKline. H.H., S.G., J.R.G., A.K., K.S., G.T. and U.T. are employees of and/or own stock or stock options in deCODE genetics.
Additional information
A full list of members is provided in the Supplementary Note.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4, Supplementary Tables 1–14 and Supplementary Note. (PDF 5386 kb)
Rights and permissions
About this article
Cite this article
Schunkert, H., König, I., Kathiresan, S. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43, 333–338 (2011). https://doi.org/10.1038/ng.784
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.784
This article is cited by
-
Structural and functional insights into the epigenetic regulator MRG15
Acta Pharmacologica Sinica (2024)
-
Targeting immune cell recruitment in atherosclerosis
Nature Reviews Cardiology (2024)
-
Identification of genetic loci jointly influencing COVID-19 and coronary heart diseases
Human Genomics (2023)
-
Mutated CYP17A1 promotes atherosclerosis and early-onset coronary artery disease
Cell Communication and Signaling (2023)
-
Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis
BMC Medicine (2023)